Voranigo (vorasidenib), a drug for certain brain tumors, was safe and well toleratedin patients with grade 3 or 4 IDH-mutant gliomas, according to short-term data presented at the 2025 Society for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback